Compare Eos Energy Enterprises Inc (EOSE) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eos Energy Enterprises Inc vs TransMedics Group Inc — how do they compare? Eos Energy Enterprises Inc trades at $2.52 (market cap $1.01B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: TransMedics Group Inc is far larger — about 2.7× Eos Energy Enterprises Inc's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Eos Energy Enterprises Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Eos Energy Enterprises Inc for 16 Days and TransMedics Group Inc for 24 Days on average.
| EOSE | TMDX | |
|---|---|---|
Market Cap | $1.01B | $2.74B |
Volume | 39,626,541 | 949,331 |
Sector | Industrials | Health |
52-Week High | $19.19 | $150.42 |
52-Week Low | $2.77 | $61.99 |
Typical Hold Time | 16 Days | 24 Days |
Enterprise Value | $1.34B | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eos Energy Enterprises (EOSE) trades at $2.52, down 18.71% in the last session, reflecting volatile sentiment despite strong revenue growth projections. The stock shows bearish technical signals with oversold RSI readings, while fundamentally the company faces significant losses with a -246.76% net income margin despite 2026 revenue doubling to $214 million. Recent positive developments include an $87 million DOE loan advance and a major Google partnership announced September 2, 2026.
While analyst consensus suggests substantial upside with a $7.10 price target, EOSE carries high risk due to persistent negative cash flow and profitability challenges. The company's zinc-based energy storage technology shows promise in a growing market, but execution risk remains elevated as scaling continues. Investors should weigh the growth potential against the company's current financial instability.
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Eos Energy Enterprises Inc
Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.
Read more on EOSE →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
